PANCREATIC DUCTAL CARCINOMA
Clinical trials for PANCREATIC DUCTAL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new PANCREATIC DUCTAL CARCINOMA trials appear
Sign up with your email to follow new studies for PANCREATIC DUCTAL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New pill shows promise in early trial for Hard-to-Treat cancers
Disease control CompletedThis early-stage study tested a new daily pill, JAB-3312, in 40 adults with advanced solid tumors (like lung, colon, or breast cancer) that had stopped responding to standard treatments. The main goal was to find the safest dose and check for side effects. Researchers also looked…
Matched conditions: PANCREATIC DUCTAL CARCINOMA
Phase: PHASE1 • Sponsor: Jacobio Pharmaceuticals Co., Ltd. • Aim: Disease control
Last updated Jun 15, 2026 18:55 UTC
-
New drug combo shows promise in early cancer trial
Disease control CompletedThis early-phase study tested a combination of two experimental drugs (vobramitamab duocarmazine and lorigerlimab) in 31 people with advanced solid tumors like prostate, melanoma, and pancreatic cancer. The main goal was to check safety and find the right dose. Participants recei…
Matched conditions: PANCREATIC DUCTAL CARCINOMA
Phase: PHASE1 • Sponsor: MacroGenics • Aim: Disease control
Last updated Jun 05, 2026 12:08 UTC